NASDAQ:OSIS

OSI Systems (NASDAQ: OSIS) Q4 Earnings Preview: Growth Expected Amidst Valuation Concerns

Font: Financial Modeling Prep  • Aug 20, 2026

Market Chart
  • Analysts project OSI Systems to report strong fourth-quarter earnings, with an estimated EPS of $3.77, marking an increase from $3.24 in the previous year.
  • The company is also expected to see revenue growth, with a consensus estimate of approximately $529.72 million, a 4.6% rise year-over-year.
  • Despite a "Buy" rating from B of A Securities, OSI Systems is currently considered "Modestly Overvalued" by GuruFocus, with a trailing twelve-month Price-to-Earnings (P/E) ratio of 24.55.

OSI Systems, Inc. (NASDAQ: OSIS) is set to release its fourth-quarter earnings report on August 20, 2026. The company designs and manufactures specialized electronic systems. It operates through three main segments: Security, Optoelectronics and Manufacturing, and Healthcare, providing products for critical applications in these fields.

Wall Street analysts are forecasting earnings per share (EPS) of $3.77 for the quarter. This would be an increase from the $3.24 per share reported in the same period last year. EPS is a key indicator of a company's profitability, calculated by dividing its profit by the number of outstanding shares.

The consensus revenue estimate for the quarter is approximately $529.72 million. This figure is up from the $504.99 million reported in the prior year, representing a 4.6% rise. This follows a positive trend, as OSI Systems previously posted better-than-expected third-quarter earnings and confirmed its guidance for the 2026 fiscal year.

Analyst actions provide further insight. As highlighted by Benzinga, B of A Securities analyst Mariana Perez Mora maintained a Buy rating on OSI Systems. However, the price target was adjusted downward from $315.00 to $300.00 on July 20, 2026. The stock recently closed at $220.92 after a 1% increase.

From a valuation perspective, GuruFocus has assigned OSI Systems a GF Value of $191.80, labeling the stock as "Modestly Overvalued." The company's trailing twelve-month Price-to-Earnings (P/E) ratio is 24.55. The P/E ratio helps investors gauge a stock's value by comparing its share price to its earnings per share.

Market Overview
HOWL
Werewolf Therapeutics, Inc.
$0.87
102.57%
TSLL
Direxion Daily TSLA Bull 2X ETF
$9.77
10.02%
KNRX
Knorex Ltd.
$0.52
57.58%
GOSS
Gossamer Bio, Inc.
$0.15
-1.78%
IBIT
iShares Bitcoin Trust ETF
$43.68
6.02%
BITO
ProShares Bitcoin ETF
$10.41
6.12%
MARA
Marathon Digital Holdings, Inc.
$11.26
0.99%
LGCL
Lucas GC Limited Ordinary Shares
$0.06
-31.33%
NVDA
NVIDIA Corporation
$214.72
-0.98%
CAN
Canaan Inc.
$0.36
27.29%